CAMK1D and breast carcinoma in situ: In addition, tumor-related studies have found that CAMK1D expression is higher in invasive breast cancer than in situ breast cancer and that overexpression of CAMK1D in breast epithelial cells promotes molecular and phenotypic alterations in epithelial–mesenchymal transition (EMT) (15).